NOX
Noxopharm Limited
1 day chart
About NOX
Noxopharm is an Australian publicly listed (NOX) clinical stage drug development company that has a primary focus on the development of Veyonda as an adjuvant therapy in chemotherapy and radiotherapy in the treatment of late-stage cancers.
Buy Australian shares starting with NOX. Invest today with a CHESS-sponsored investing platform!
Market Capitalisation
$12M
Price-earnings ratio
-0.78
Dividend yield
NaN%
High today
$0.04
Low today
$0.04
Open price
$0.04
52-week high
$0.22
52-week low
$0.03
Announcements
NOX FAQs
Can I buy NOX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake platform allows you to buy NOX shares and over 8,000 stocks and ETFs across the ASX and Wall St.
How much is one share of Noxopharm Limited?
One share of Noxopharm Limited is valued at $0.04.
What is the ticker symbol for Noxopharm Limited?
The ticker symbol for Noxopharm Limited is NOX.
How do I buy NOX shares in Australia?
To buy NOX stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in NOX
What is the 52-week high for Noxopharm Limited stock?
The Noxopharm Limited 52-week high stock price is $0.22.
What is the 52-week low for Noxopharm Limited stock?
The Noxopharm Limited 52-week low stock price is $0.03.
What is the market capitalisation of Noxopharm Limited NOX?
As of 26/09/2023 Noxopharm Limited has a market cap of $12M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.